This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Biotech, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher W. Rode: Bioprocessing and Glycan Analysis
Introduction
Christopher W. Rode is an inventor associated with Raritan, New Jersey, and Janssen Biotech, Inc. His patent work concerns analytical methods and systems for controlling molecular characteristics in bioreactor manufacturing.
Latest Patents
Rode is named on one patent, “Multiparameter Materials, Methods and Systems for Enhanced Bioreactor Manufacture.” The patent describes using spectroscopic analysis and chemometric modeling to determine glycation on a molecule or glycan structures on a glycosylated molecule. It also covers methods and systems for producing molecules with desired glycation levels, including non-glycated molecules, and for controlling glycan structures on glycosylated molecules. His listed portfolio includes 1 patent.
Career Highlights
Rode’s documented patent activity focuses on bioreactor manufacturing and the measurement and control of molecular attributes. His work is associated with Janssen Biotech, Inc.
Collaborations
The patent lists Barry J. McCarthy and Daniel A. Trout among Rode’s coworkers. Their shared work relates to analytical and manufacturing approaches for producing molecules with specified glycation or glycan characteristics.
Conclusion
Christopher W. Rode’s patent contribution centers on applying spectroscopy and chemometric modeling to improve control over bioreactor-produced molecules and their glycan characteristics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile